Eloxx Pharmaceuticals, Inc.
ELOX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001035354
No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $40.2M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Eloxx Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +22 vs. Q1 2026
- Shares held
- 2.90M
- +2.90M vs. Q1 2026
- Total value
- $40.2M
- +$40.2M vs. Q1 2026
- New holders
- 22
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $40.2M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $43 |
| Q1 2024 | 1 | $62 |
| Q4 2023 | 4 | $109.0K |
| Q3 2023 | 18 | $2.50M |
| Q2 2023 | 16 | $924.2K |
| Q1 2023 | 19 | $671.5K |
| Q4 2022 | 19 | $476.7K |
| Q3 2022 | 32 | $2.14M |
| Q2 2022 | 32 | $3.51M |
| Q1 2022 | 36 | $8.42M |
| Q4 2021 | 39 | $11.7M |
| Q3 2021 | 41 | $26.0M |
| Q2 2021 | 47 | $33.2M |
| Q1 2021 | 38 | $28.7M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Eloxx Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 800,000 | $11.1M | 0.34% | +800,000 | New |
| EcoR1 Capital, LLC | 400,000 | $5.55M | 0.28% | +400,000 | New |
| Standard Life Aberdeen plc | 400,000 | $5.55M | 0.01% | +400,000 | New |
| Samsara BioCapital, LLC | 400,000 | $5.55M | 0.46% | +400,000 | New |
| Siren, L.L.C. | 400,000 | $5.55M | 0.11% | +400,000 | New |
| Stonepine Capital Management, LLC | 397,160 | $5.51M | 4.20% | +397,160 | New |
| Vanguard Capital Management LLC | 78,680 | $1.09M | 0.00% | +78,680 | New |
| Vanguard Fiduciary Trust Co | 10,602 | $147.2K | 0.00% | +10,602 | New |
| Seven Grand Managers, LLC | 10,000 | $138.8K | 0.01% | +10,000 | New |
| Morgan Stanley | 1,544 | $21.4K | 0.00% | +1,544 | New |
| Vanguard Global Advisers, LLC | 718 | $9.97K | 0.00% | +718 | New |
| UBS Group AG | 637 | $8.84K | 0.00% | +637 | New |
| Wells Fargo & Company | 126 | $1.75K | 0.00% | +126 | New |
| Pioneer Family Office, LLC | 96 | $1.33K | 0.00% | +96 | New |
| Royal Bank of Canada | 98 | $1.00K | 0.00% | +98 | New |
| Altshuler Shaham Ltd | 25 | $347 | 0.00% | +25 | New |
| Barclays PLC | 12 | $167 | 0.00% | +12 | New |
| Old Point Trust & Financial Services N A | 5 | $69 | 0.00% | +5 | New |
| Citigroup Inc | 4 | $56 | 0.00% | +4 | New |
| Activest Wealth Management | 4 | $56 | 0.00% | +4 | New |
| SBI Securities Co., Ltd. | 2 | $28 | 0.00% | +2 | New |
| Point Nemo Capital, LLC | 1 | $14 | 0.00% | +1 | New |